Ad5-105K

· CanSino Biologics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ad5-105K, covering 2025-12-11 to 2025-12-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of Ad5-105K in Adults Aged 18 to 49 Years [Phase 1]